# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-065335
Filing Date
2022-10-21
Accepted
2022-10-21 06:12:29
Documents
5
Period of Report
2022-10-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea167405-6k_immuron.htm | 6-K | 13415
2 | NOTICE OF ANNUAL GENERAL MEETING/PROXY FORM | ea167405ex99-1_immuron.htm | EX-99.1 | 215092
3 | GRAPHIC | image_001.jpg | GRAPHIC | 1254
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 270623
5 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 266690
| Complete submission text file | 0001213900-22-065335.txt |  | 971319

Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 221322151
SIC: 2834 Pharmaceutical Preparations